CannaMD

NOVEMBER 20, 2020

a wealth of new research legitimizing marijuana’s role in patient care – here we are. Between 2000-2018, United States funding sources invested roughly 20 times more money into exposing marijuana’s harms than exploring its benefits. For more details, see: Best Cannabis Disorder Treatment? The Mississippi Monopoly.

Therapy 79

Therapy Treatment DEA CBD 79

Cannabis Law Report

SEPTEMBER 12, 2021

Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. Nevada voters approved medical marijuana for people by ballot initiative in 2000. But do medical cannabinoids actually help animal patients? Earlier this year, Gov. A simple question.

Patients 105

Patients Pets Seed-To-Sale Cannabinoids 105

CannaMD

NOVEMBER 15, 2020

His findings are sure to alarm medical cannabis professionals and patients alike. research funders, the National Institute on Drug Abuse (NIDA) , spent over $1 billion between 2000 and 2008, with a heavily slanted focus on cannabis abuse and misuse, as well as the negative effects of cannabis. Funding of Marijuana Research.

DEA 105

DEA Clinical Trials Cannabinoids Treatment 105

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Later that year, Doblin sued the DEA for the first time. Rick Doblin, Ph.D., and Michael Mithoefer, M.D., Lyle Craker, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52